Indian Journal of Nuclear Medicine

EDITORIAL
Year
: 2017  |  Volume : 32  |  Issue : 1  |  Page : 11--12

Specificity of 68Ga-PSMA PET/CT for prostate cancer - myths and reality


Arun Sasikumar 
 Consultant Nuclear Medicine and PET/CT, KIMS-DDNMRC, KIMS hospital North Block, Anayara P.O, Thiruvananthapuram, Kerala, India

Correspondence Address:
Arun Sasikumar
Consultant Nuclear Medicine and PET/CT, KIMS-DDNMRC, KIMS hospital North Block, Anayara P.O, Thiruvananthapuram, Kerala
India

68Ga-PSMA ligand PET/CT for imaging prostate cancer is a novel imaging technique, which is rapidly gaining popularity. Sufficient evidence has been accumulated in literature regarding the usefulness of 68Ga-PSMA PET/CT in prostate cancer. Recently literature regarding the localization of 68Ga-PSMA PET/CT imaging in non-prostatic malignancies is also published, thus questioning the specificity of the tracer with regards to prostate cancer. This commentary tries to address the issue of specificity of 68Ga-PSMA PET/CT and its relevance in imaging prostate cancer.


How to cite this article:
Sasikumar A. Specificity of 68Ga-PSMA PET/CT for prostate cancer - myths and reality.Indian J Nucl Med 2017;32:11-12


How to cite this URL:
Sasikumar A. Specificity of 68Ga-PSMA PET/CT for prostate cancer - myths and reality. Indian J Nucl Med [serial online] 2017 [cited 2020 Aug 14 ];32:11-12
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2017;volume=32;issue=1;spage=11;epage=12;aulast=Sasikumar;type=0